ATE412900T1 - Standard - Google Patents

Standard

Info

Publication number
ATE412900T1
ATE412900T1 AT04744299T AT04744299T ATE412900T1 AT E412900 T1 ATE412900 T1 AT E412900T1 AT 04744299 T AT04744299 T AT 04744299T AT 04744299 T AT04744299 T AT 04744299T AT E412900 T1 ATE412900 T1 AT E412900T1
Authority
AT
Austria
Prior art keywords
compact
compact particle
medium
reference standard
particle
Prior art date
Application number
AT04744299T
Other languages
English (en)
Inventor
Lars Winther
Kurt Pii
Original Assignee
Dako Denmark As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dako Denmark As filed Critical Dako Denmark As
Application granted granted Critical
Publication of ATE412900T1 publication Critical patent/ATE412900T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36—Embedding or analogous mounting of samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N2001/2893—Preparing calibration standards
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Resistance Heating (AREA)
AT04744299T 2003-07-08 2004-07-08 Standard ATE412900T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0315991.0A GB0315991D0 (en) 2003-07-08 2003-07-08 Standard
US48638103P 2003-07-11 2003-07-11

Publications (1)

Publication Number Publication Date
ATE412900T1 true ATE412900T1 (de) 2008-11-15

Family

ID=33566552

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04744299T ATE412900T1 (de) 2003-07-08 2004-07-08 Standard

Country Status (8)

Country Link
US (2) US20060154234A1 (de)
EP (1) EP1642131B1 (de)
JP (1) JP4741486B2 (de)
AT (1) ATE412900T1 (de)
DE (1) DE602004017466D1 (de)
ES (1) ES2317002T3 (de)
GB (1) GB0315991D0 (de)
WO (1) WO2005003773A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304515D0 (en) * 2003-02-27 2003-04-02 Dakocytomation Denmark As Standard
US20090208981A1 (en) * 2005-05-03 2009-08-20 Jia-Ming Chang Method for Analysis of Interaction Between Small Molecules and Cells and Apparatus thereof
JP4734636B2 (ja) * 2005-11-02 2011-07-27 国立大学法人 鹿児島大学 免疫染色法、及び当該免疫染色法を利用した細胞の評価方法
PL1920781T3 (pl) 2006-11-10 2015-06-30 Glycotope Gmbh Kompozycje zawierające core-1-dodatnie mikroorganizmy i ich zastosowanie w leczeniu lub profilaktyce nowotworów
US20100143935A1 (en) * 2006-12-01 2010-06-10 Apocell, Inc. c-KIT Phosphorylation in Cancer
DE102007041912A1 (de) * 2007-09-04 2009-03-05 Siemens Ag Verfahren zur Darstellung von Bilddaten mehrerer Bilddatenvolumina in wenigstens einer gemeinsamen Bilddarstellung und zugehörige medizinische Einrichtung
US20090226059A1 (en) * 2008-02-12 2009-09-10 Richard Levenson Tissue Processing And Assessment
JP2011520435A (ja) 2008-05-13 2011-07-21 グリコトープ ゲーエムベーハー 発酵プロセス
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
JP2012501658A (ja) * 2008-09-05 2012-01-26 ライフ テクノロジーズ コーポレーション 核酸配列決定の検証、較正、および標準化のための方法およびシステム
US20100099199A1 (en) * 2008-10-22 2010-04-22 Leica Biosystems Nussloch Gmbh Method and apparatus for ascertaining reagent quality
JP5733734B2 (ja) 2009-02-19 2015-06-10 国立大学法人 千葉大学 成長因子に誘発されるユークロマチン化（ｅｕｃｈｒｏｍａｔｉｎｉｚａｔｉｏｎ）に必要な、ＳＲＣ−ファミリーチロシンキナーゼの核局在
US9169515B2 (en) * 2010-02-19 2015-10-27 Life Technologies Corporation Methods and systems for nucleic acid sequencing validation, calibration and normalization
EP3779433A3 (de) 2010-08-30 2021-05-19 Konica Minolta, Inc. Gewebefärbeverfahren, gewebeauswertungsverfahren und verfahren zum nachweis von biosubstanzen
JP5543888B2 (ja) * 2010-09-29 2014-07-09 富士フイルム株式会社 イムノクロマトグラフ検査方法および装置
EP2627984B1 (de) 2010-10-12 2017-08-16 Life Technologies Corporation Verfahren zur herstellung eines qualitätskontrollmaterials für ffpe
KR101224964B1 (ko) * 2011-01-28 2013-01-22 현대제철 주식회사 슬라브내 핀홀 분포 분석장치 및 분석방법
ES2686313T3 (es) 2011-08-22 2018-10-17 Glycotope Gmbh Microorganismos que portan un antígeno tumoral
US10758487B2 (en) * 2011-12-09 2020-09-01 The Johns Hopkins University Artificial antigen presenting cells having a defined and dynamic shape
PT106082A (pt) * 2012-01-04 2013-07-04 Fernando Jorge Neves Ferreira Composição fixadora para citologia, método de fixação de células e suas aplicações
US10197479B1 (en) 2012-03-14 2019-02-05 Alamak Biosciences Incorporation Company Limited In vitro homogenous DNA and RNA cell blocks made using a multi-chambered rotating apparatus
US9395283B1 (en) 2012-03-14 2016-07-19 Alamak Biosciences Incorporation Company Limited In vitro homogenous cell block, method of making and using
KR20150029017A (ko) 2012-07-10 2015-03-17 박스터 헬쓰케어 에스에이 항-mif 면역조직화학
WO2015017535A2 (en) * 2013-08-02 2015-02-05 Siemens Healthcare Diagnostics Inc. Cell-based control and method
USD734483S1 (en) * 2013-12-31 2015-07-14 Alamak Biosciences Incorporation Company Limited Tissue cell block for cancer detection
USD739549S1 (en) 2013-12-31 2015-09-22 Alamak Biosciences Incorporation Company Limited Tissue cell block
JP5993967B2 (ja) * 2014-02-20 2016-09-21 国立大学法人秋田大学 細胞内生体分子の検出に用いる標準試料及び細胞内生体分子の検出方法
GB201403605D0 (en) * 2014-02-28 2014-04-16 Mologic Ltd Monitoring inflammation status
JP6313123B2 (ja) * 2014-05-28 2018-04-18 東京エレクトロン株式会社 測定装置及び測定方法
JP6328493B2 (ja) * 2014-05-28 2018-05-23 東京エレクトロン株式会社 測定装置及び測定方法
EP3212315A4 (de) 2014-10-31 2018-07-11 Massachusetts Institute of Technology Zusammensetzungen und verfahren zur herstellung von emulsionen
TWI530674B (zh) 2014-11-06 2016-04-21 財團法人工業技術研究院 金奈米簇組成物與其製備方法及含硫醇基物質的檢測方法
JP5972412B2 (ja) * 2015-02-05 2016-08-17 国立大学法人秋田大学 培養細胞を用いた標準試料及びその製造方法
EP3371594A1 (de) * 2015-11-06 2018-09-12 Ventana Medical Systems, Inc. Repräsentative diagnose
GB201603459D0 (en) * 2016-02-29 2016-04-13 Ge Healthcare Uk Ltd Solid support for sample collection
US20190170737A1 (en) 2016-09-19 2019-06-06 Massachusetts Institute Of Technology Systems including janus droplets
US11300486B1 (en) * 2016-11-23 2022-04-12 Array Science, Llc Apparatus for producing high yield cores for use in a microarray block, method for using same
JP6727722B2 (ja) * 2016-11-29 2020-07-22 株式会社日立製作所 気流型分析システムの標準試料作成方法
JP6850600B2 (ja) * 2016-12-21 2021-03-31 オリンパス株式会社 標準試料および顕微鏡の調整方法
US11795424B2 (en) * 2017-02-15 2023-10-24 University Public Corporation Osaka Cell culture vessel, sample observation cell, and cell culture method
DE102017106867B4 (de) * 2017-03-30 2021-12-02 Hamilton Bonaduz Ag Verfahren zur Herstellung einer Portionseinheit
JP2020098097A (ja) * 2017-03-31 2020-06-25 松浪硝子工業株式会社 スライドグラス及びスライドグラスの製造のための溶液
WO2018209178A1 (en) 2017-05-11 2018-11-15 The Research Foundation For The State University Of New York Method and kit for determining the presence of monosodium urate crystals in joint synovial fluid
WO2019111355A1 (ja) * 2017-12-06 2019-06-13 オリンパス株式会社 学習モデル作成方法、画像処理方法、学習モデル作成装置、画像処理装置、学習モデル作成プログラム、及び画像処理プログラム
TWI669616B (zh) * 2018-08-13 2019-08-21 行政院原子能委員會核能研究所 圓柱狀和圓餅狀數位模型之模擬切割方法
US10921223B2 (en) 2018-10-12 2021-02-16 Shenzhen Prs Limited Process record slide for staining and method of using the same
IT201900007227A1 (it) * 2019-05-24 2020-11-24 Univ Degli Studi Di Salerno Kit e metodo per il rilevamento di contaminanti chimici su superfici
CN110376036A (zh) * 2019-07-30 2019-10-25 河南赛诺特生物技术有限公司 一种肿瘤细胞系免疫组化对照品的制备方法及肿瘤细胞系免疫组化对照品
US12274993B2 (en) 2019-09-18 2025-04-15 Massachusetts Institute Of Technology Systems and methods for affecting interactions of electromagnetic radiation with janus droplets for sensitive detection of species
CN114867557B (zh) * 2019-12-20 2024-06-07 罗氏血液诊断股份有限公司 线性对照组合物和使用方法
AU2021213150A1 (en) 2020-01-30 2022-08-04 Prognomiq Inc Lung biomarkers and methods of use thereof
WO2022156920A1 (en) * 2021-01-25 2022-07-28 Ventana Medical Systems, Inc. Stained biological specimens including one or more biomarkers labeled with one or more detectable moieties
WO2022212583A1 (en) 2021-03-31 2022-10-06 PrognomIQ, Inc. Multi-omic assessment
IT202100011903A1 (it) * 2021-05-10 2022-11-10 Diapath S P A Procedimento per il trattamento di campioni biologici, citologici, istologici e autoptici.
WO2023039479A1 (en) 2021-09-10 2023-03-16 PrognomIQ, Inc. Direct classification of raw biomolecule measurement data
CN118215845A (zh) 2021-09-13 2024-06-18 普罗科技有限公司 增强的对生物分子的检测和定量
WO2024072614A1 (en) * 2022-09-27 2024-04-04 Nautilus Subsidiary, Inc. Polypeptide capture, in situ fragmentation and identification
DE102022134504A1 (de) * 2022-12-22 2024-06-27 Technische Universität Dresden, Körperschaft des öffentlichen Rechts Verfahren und gerät zur schichtdickenbestimmung histologischer schnittpräparate und konzentrationsbestimmung von biologischen substanzen in histologischen präparaten

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879178A (en) * 1956-06-29 1959-03-24 Rohm & Haas Coated leather products and methods for producing them
NL266144A (de) * 1960-06-20 1900-01-01
NL266645A (de) * 1960-07-05
US3497485A (en) * 1965-09-07 1970-02-24 Rohm & Haas Acryloxyalkyloxyalkyl ketimines and aldimines,polymers thereof,primary amine monomers and polymers,and processes for producing the monomeric and polymeric imines and amines
US3502627A (en) * 1966-01-06 1970-03-24 Rohm & Haas N-acryl(polyoxyalkyl)-oxazolidines and n - acryl(polyoxyalkyl) - tetrahydro-1,3-oxazines and salts thereof
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
US4529712A (en) * 1981-09-18 1985-07-16 Research Corporation Coated cells and their use
GB8813628D0 (en) * 1988-06-09 1988-07-13 Shandon Southern Prod Immunostaining
US4990245A (en) * 1989-06-08 1991-02-05 The Permutit Company Sequence controller system for regenerating water treatment units
US5610022A (en) * 1989-09-26 1997-03-11 City Of Hope Internal control for immunocytochemistry assay
DE4313908A1 (de) * 1993-04-28 1994-11-03 Huels Chemische Werke Ag Wasserenthärtende Formulierungen
DE4317302A1 (de) * 1993-05-25 1994-12-01 Degussa Leitfähige Bodenbeschichtung
DE4319199A1 (de) * 1993-06-09 1994-12-15 Roehm Gmbh Kratzfeste antisoiling- und antigraffity-Beschichtung für Formkörper
DE4320660A1 (de) * 1993-06-22 1995-01-05 Basf Ag Verfahren zur Reduzierung des Wandbelages bei der Suspensionspolymerisation von Acryl- und/oder Methacrylgruppen-haltigen Monomeren
US5951976A (en) * 1996-03-28 1999-09-14 Whitenead Institute For Biomedical Research Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
US20020127205A1 (en) * 1998-08-31 2002-09-12 Albert Edge Cells expressing immunoregulatory molecules and uses therefor
AU770729B2 (en) * 1998-10-21 2004-02-26 Steven Jay Smith Protein quantitation with cell imaging densitometry
US6696304B1 (en) * 1999-02-24 2004-02-24 Luminex Corporation Particulate solid phase immobilized protein quantitation
US6713309B1 (en) * 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture
US20020197656A1 (en) * 1999-12-17 2002-12-26 Ronghao Li Cell arrays and the uses thereof
DE10002803A1 (de) * 2000-01-24 2001-08-02 Conbio Lizenzverwertungsgesell System zur internen qualitativen und quantitativen Validierung von Markerindices
US6849423B2 (en) * 2000-11-29 2005-02-01 Picoliter Inc Focused acoustics for detection and sorting of fluid volumes
WO2003016867A2 (en) * 2001-08-21 2003-02-27 Ventana, Medical, Systems, Inc Method and quantification assay for determining c-kit/scf/pakt status

Also Published As

Publication number Publication date
EP1642131A1 (de) 2006-04-05
JP2007527991A (ja) 2007-10-04
US20160054300A1 (en) 2016-02-25
EP1642131B1 (de) 2008-10-29
US20060154234A1 (en) 2006-07-13
JP4741486B2 (ja) 2011-08-03
DE602004017466D1 (en) 2008-12-11
WO2005003773A1 (en) 2005-01-13
ES2317002T3 (es) 2009-04-16
GB0315991D0 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
ATE412900T1 (de) Standard
DE60329287D1 (de) Boehmitteilchen und diese enthaltende polymermaterialien
ATE444119T1 (de) Chromatographisches medium
ATE352631T1 (de) Heterologe expression von neisseria proteine
ZA200200097B (en) Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof.
DE60118977D1 (de) Differentialverstärker mit grossem gleichtaktbereich
EP1657071A4 (de) Aufzeichnungsmedium
EP2302383A3 (de) Docetaxel Konjugaten und Immunogenen zur Verwendung in einem Immunassay
IS2811B (is) Notkun á HPV16 og HPV18 veirulíkum ögnum gegn einni eða fleiri af æxlisvaldandi HPV gerðum 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
DE60114804D1 (de) Konstruierte fluoreszenzproteine mit langen wellenlängen
DE60206056D1 (de) Herstellung von polymerteilchen
DE60106442D1 (de) PARTIKEL UND IHRE VERWENDUNG IN MOLEKULARER Prägung
EA200700727A1 (ru) Способ изготовления твердого душистого вещества
DE502006001569D1 (de) Verwendung eines Materials als Lumineszenzstandard zur Referenzierung von Lumineszenzsignalen
DE60105079D1 (de) Informationsempfänger mit Standortübermittlung des Empfängers
ATE382062T1 (de) Antikörper gegen allgegenwärtige mitochondriale kreatinkinase und dessen verwendung
Hansen Laboratory directed research and development FY2002 report
DE60304096D1 (de) Kompaktes abnehmbares magnetisches Aufzeichnungsmittel
ATE334215T1 (de) Verwendung des aminoglycosidresistenzgens
AU2003232724A1 (en) A novel biological cancer marker and methods for determining the cancerous or non-cancerous phenotype of cells
ES1055741U (es) Soporte de turbina, resistencia y termostato para chimeneas o estufas.
FR2841032B1 (fr) Support d'enregistrement magnetique
FR2849039B1 (fr) Nouvelle proteine associee aux centrosomes et ses applications
Darrigrand 852-850 (part of the Arrigo Park series)
Jacobsohn et al. EPA & EREF Measure Mercury Emissions.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties